Correlation Between Dorman Products and BioMark Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dorman Products and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dorman Products and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dorman Products and BioMark Diagnostics, you can compare the effects of market volatilities on Dorman Products and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dorman Products with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dorman Products and BioMark Diagnostics.

Diversification Opportunities for Dorman Products and BioMark Diagnostics

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Dorman and BioMark is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Dorman Products and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Dorman Products is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dorman Products are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Dorman Products i.e., Dorman Products and BioMark Diagnostics go up and down completely randomly.

Pair Corralation between Dorman Products and BioMark Diagnostics

Given the investment horizon of 90 days Dorman Products is expected to generate 0.78 times more return on investment than BioMark Diagnostics. However, Dorman Products is 1.28 times less risky than BioMark Diagnostics. It trades about 0.2 of its potential returns per unit of risk. BioMark Diagnostics is currently generating about -0.16 per unit of risk. If you would invest  11,596  in Dorman Products on September 13, 2024 and sell it today you would earn a total of  2,388  from holding Dorman Products or generate 20.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy97.73%
ValuesDaily Returns

Dorman Products  vs.  BioMark Diagnostics

 Performance 
       Timeline  
Dorman Products 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Dorman Products are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Dorman Products displayed solid returns over the last few months and may actually be approaching a breakup point.
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Dorman Products and BioMark Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dorman Products and BioMark Diagnostics

The main advantage of trading using opposite Dorman Products and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dorman Products position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.
The idea behind Dorman Products and BioMark Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities